Motorica has begun manufacturing its Indy Hand, a single-grip myoelectric forearm prosthesis, at an Indian partner’s facility in Ghaziabad, Uttar Pradesh. The company describes it as its first international transfer of manufacturing technology: its specialists trained local staff and introduced production and quality-control processes, and several dozen devices have already been produced, some of them fitted to users.
The move takes Motorica from serving India through a regional presence and clinical partners to making at least one product in-country, with plans to add more of its range. What the announcement does not yet show is production capacity, pricing against imported devices, local component sourcing, or how warranty, spare parts and repairs will be delivered across India’s regions.
Deliberate perspective
For O&P manufacturers looking at India, local production can shorten supply chains, ease price pressure and strengthen a company’s position with government and CSR-funded buyers. But it is only one part of market entry. The questions that decide success are commercial and clinical:
- Partner choice: technology transfer depends on a manufacturing partner with the quality systems, capacity and regulatory standing to sustain it
- Regulatory pathway: locally made devices still need the right CDSCO classification and registration
- Service network: myoelectric devices need trained prosthetists, control training and follow-up, so the clinical channel matters as much as the factory
- Funding routes: pricing has to work for ADIP, CSR programmes, insurers and private payers
Localisation is a strong signal of long-term commitment. Getting the partner, registration and service model right first is what turns it into sustained sales.
Read the full article on Bharat CPO.
